Unbound MEDLINE

Global Measles and Rubella Laboratory Network, January 2004-June 2005. MMWR. Morbidity and mortality weekly report. [MMWR Morb Mortal Wkly Rep] Journal article

 
TitleGlobal Measles and Rubella Laboratory Network, January 2004-June 2005.
Author(s)Centers for Disease Control and Prevention (CDC) 
SourceMMWR Morb Mortal Wkly Rep 2005 Nov 4; 54(43):1100-4.
MeSHGenotype
Humans
Laboratory Techniques and Procedures
Measles
Measles virus
Population Surveillance
Rubella
Rubella virus
World Health
World Health Organization
AbstractMeasles continues to be a leading cause of childhood morbidity and mortality in developing countries and an outbreak threat in the majority of countries. In 2000, measles was considered the fifth leading cause of childhood mortality, and the World Health Organization (WHO) estimated that approximately 777,000 measles-associated deaths occurred worldwide. In 2001, WHO and the United Nations Children's Fund (UNICEF) developed a 5-year strategic plan, endorsed by the World Health Assembly in 2003, to reduce measles mortality by 50% by 2005 (relative to 1999 estimates) and to achieve and maintain interruption of indigenous measles transmission in large geographic areas with established measles elimination goals. This plan included strengthening routine vaccination coverage, providing a second opportunity for measles immunization to children, improving measles case management, and improving surveillance with laboratory confirmation of suspected measles cases. To date, four of six WHO regions have established measles elimination targets: the Americas Region (AMR) by 2000, the European Region (EUR) by 2010, the Eastern Mediterranean Region (EMR) by 2010, and the Western Pacific Region (WPR) by 2012. The remaining two WHO regions, the African (AFR) and South East Asian (SEAR) regions, are continuing work toward the measles mortality reduction goal. Likewise, to reduce the burden of disease from congenital rubella syndrome (CRS), currently estimated at 100,000 cases per year worldwide, several countries have developed or continue to develop rubella control programs, and AMR and EUR have established regional rubella elimination and CRS reduction goals, respectively. Because improved global surveillance is essential for monitoring progress toward mortality reduction and elimination of these diseases, WHO established the Measles and Rubella Laboratory Network (LabNet) in 2003 to promote case identification and confirmation. This report provides an update on the development of LabNet during January 2004-June 2005 and describes the geographic distribution of measles and rubella virus genotypes as of June 2005.
Languageeng
Pub Type(s)Journal Article
PubMed ID16267497
  
Advertise on this site.